Ĩkon magungunan cutar daji kara hadarin cututtukan zuciya?

A rare lokuta, m kwayoyi, wanda sa tsarin na rigakafi don yaki da ciwon daji, zai iya lahanta zuciya. Wannan ne ya ruwaito ta hanyar bincike.

Wannan immunotherapy kwayoyi. A cikin 'yan shekaru, sun gaba daya ya canza aiwatar da magani daga ciwon daji, kamar yadda wasu marasa lafiya da suke dogara kawai a kan aiki ya fara a gafarta musu.

A farko lokuta da mutuwa

Duk da haka, a kan Nuwamba 3, "New England Journal of Medicine" yana mai bayanin irin biyu lokuta, a lokacin da marasa lafiya a cikin marigayi matakai na melanoma mutu daga cututtukan zuciya da makonni biyu bayan samun su da farko kashi na kwayoyi kamar Opdivo (Nivolumab) da kuma Yervoy (Ipilimumab).

Daya daga cikin marasa lafiya da aka a 65-shekaru mace wanda ya mutu daga zuciya rashin cin nasara, yayin da wasu da aka a 63-shekara mutumin wanda ya mutu bayan biyu lokuta na kwatsam bugun zuciya. A lokacin da wani ciwon zuciya, jini ya kwarara zuwa cikin zuciya da aka katange, abu don nama lalacewa, yayin da a yanayin saukan kwatsam bugun zuciya, shi daina doke gabã ɗaya.

A hadarin yin amfani da irin wannan kwayoyi

A rahoton kuma kara da cewa biyu irin wannan samfurin a kasuwa - Tecentriq (Atezolizumab), wani magani da mafitsara da ciwon daji, kuma Keytruda (Pembrolizumab), wanda aka yi amfani da magani ya watsu cikin kwakwalwa melanoma a cikin tsohon shugaban kasar Amurka Jimmy Carter - iya zama irin wannan hadari .

Duk da haka, lokuta da zuciya lalacewa ne sosai ɗai ɗai, da kuma kasa da 1%. An zaci cewa hadarin shi ne mafi girma a lokacin da biyu kwayoyi da ake dauka a lokaci guda, ƙara da mawallafa na rahoton.

gwani shaida

Da masu bincike sun jaddada cewa, matsalolin da ya kamata ba detract daga cikin amfanin wadannan kwayoyi don ciwon daji marasa lafiya.

"Wannan shi ne wani sabon, a baya ba a sani ba wahala na yiwuwar rai ceton magunguna," - ya ce binciken ta m marubucin, Dr. Javid Moslehi. Shi ne darektan da School of Medicine a Nashville.

"Muna kokarin samar da wani bayani ga wannan matsala. Our aiki ne ba don gane wadannan miyagun wayoyi, da kuma inganta halin da ake ciki ", - ya ce Moslehi.

Marasa lafiya da shan wadannan kwayoyi ya kamata a hankali da sanya idanu. Idan suka sami wannan sabon matsalar, za ka bukatar ka da sauri ba su kwayoyi da canza tsarin na rigakafi martani - da masu bincike sun ce.

Dr. Michael Atkins, mataimakin darektan Georgetown-Lombardi da cikakkiyar Cancer Center a Washington, DC, ya yi imanin cewa zuciya matsaloli sa da wadannan kwayoyi, shi za a iya warware. Atkins yake lura da binciken, a lokacin da ya mutu daga biyu marasa lafiya. "Wannan shi ne rare harka ... amma shi ne musamman tsanani", - ya ce.